Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Trump is about to crash drug prices - and Big Pharma is terrified
Less than a year ago, Pharmaceutical Research and Manufacturers of America (PhRMA) CEO Stephen Ubl stated PhRMA would be “answering Trump's call” to put America first in the healthcare ecosystem. However, as President Donald Trump…
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil, Switzerland – July 27, 2026 Idorsia Ltd (SIX: IDIA) has entered into an…
Format, loading, ingredients: Sirio Pharma on tackling APAC's oral beauty market
Beauty-from-within was the second-largest category in Asia-Pacific's vitamin and dietary supplement sector last year and Sirio Pharma says it is focusing on key progress in its ingredient and dosage innovations in securing greater market shares in…
This Stock Of The Day Dines On Big Pharma Royalties; Up 56% In 2026
Ligand Pharmaceuticals Ligand Pharmaceuticals LGND $ 294.12 $6.42 2.13% 6% IBD Stock Analysis Shares could rebound from 21-day exponential line, or possible form a flat base. If stock continues lower, watch for a rebound from the 50-day moving…
.jpg)
Big Pharma Wants To Turn Toad Venom Into The Next Blockbuster Drug
Big Pharma is making a high-stakes bet that their next cash grab will come from an unlikely source: the psychedelic venom of toads. Pharmaceutical companies are pouring billions into a drug called 5-MeO-DMT, often known as bufo, a powerful…
AstraZeneca boss urges western drugmakers to move at 'Chinese speed'
AstraZeneca must operate at “Chinese speed” to ensure it doesn't suffer the fate of the western automotive industry by losing out to more innovative rivals, the drug company's boss has said. The FTSE 100 company is watching the rise…
Avalyn Pharma (NASDAQ:AVLN) Shares Gap Down - Time to Sell?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) gapped down before the market opened on Monday. The stock had previously closed at $29.73, but opened at $28.25. Avalyn Pharma shares last traded at $28.37, with a volume of 1,744 shares. Several…
Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 5.2% - What's Next?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares were down 5.2% on Monday. The stock traded as low as $18.32 and last traded at $18.32. Approximately 573 shares were traded during mid-day trading, a…
argenx To Acquire Forte Biosciences: What Investors Should Know (NASDAQ:ARGX)
argenx SE is acquiring Forte Biosciences, Inc. for $2.2bn, paying a substantial premium to gain FB-102, a first-in-class anti-CD122 antibody. FB-102 offers clinical proof-of-concept in vitiligo and celiac disease, aligning with ARGX's strategy to…
Merck inks pact with four generic drugmakers in India for HIV drug
Pharma major Merck (known as MSD outside of the U.S. and Canada) has signed non-exclusive voluntary licensing agreements with generic drugmakers Aurobindo Pharma, Cipla, Emcure and Viatris in India to enable supply of its investigational…
/afaqs/media/media_files/2026/07/27/novovslilly-2026-07-27-20-13-59.png)
Novo Nordisk sues Eli Lilly over misleading ad claims
Novo Nordisk has taken Eli Lilly to court, accusing its rival of running advertising that unfairly makes its weight loss and diabetes drugs look more effective than Novo's own, as reported by Reuters. At the heart of the dispute is dosage. Novo…
Here are Monday's biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, AMD, GM, Ford, Rivian & more
Here are Monday's biggest calls on Wall Street: Piper Sandler upgrades Rivian and Mobileye to overweight from neutral Piper said both stocks are compelling. ' RIVN: a de-risked balance sheet, a smooth R2 ramp, and an improved demand outlook.....
Chiron Real Estate: A High-Yield REIT Idea Amid Shift To Senior-Care (NYSE:XRN)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
This automation tech turns old tractors into self-driving farming machines
Show me a farmer, said Mike Burdick, vice president of Sabanto, an autonomous tractor startup in Itasca, Illinois, and I'll show you someone who has a million things he or she just doesn't have time to do in the course of their workday. He'll also…
Receive a Daily briefing on Pharma Industry News
Get Started